It's hard to answer your first question with confidence - we'd...

It's hard to answer your first question with confidence - we'd need Exopharm Management or its lawyers/bankers to confirm.

With regard to a deal, it's reasonable to expect one over the next 6 months given they completed 2 over CY2022. However, the nature of the deal is more important - another 'exploratory' agreement will not necessarily help short-term funding needs. What I'm most interested in is the impending revenue-generating agreement with FRCBS. If a deal is to eventuate, it would likely occur over the next 6 months.